1. Extemporaneous drug formulations
2. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products;Glass;J Pharm Pharm Sci,2006
3. US-FDA . The special risks of pharmacy compounding, 2012. Available: https://www.pharmwatch.org/reports/compounding_risks.pdf [Accessed 23 Aug 2017].
4. Anon . U.S. Pharmacopeia and National Formulary, USP <795> rev. Rockville: United States Pharmacopeial Convention, Incorporated, 2014.
5. Potential risks of pharmacy compounding;Gudeman;Drugs in R&D,2013